BridgeBio Oncology Therapeutics Ord Shs
BBOT12.180USD
-0.340-2.72%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
286.34MMarket Cap
60.33P/E TTM
BridgeBio Oncology Therapeutics Ord Shs Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
0.36
--
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its Earnings Per Share (EPS) was 0.359, with a year-on-year change of --.
What is the net income of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its net income was 7.60M, with a year-on-year change of --.
What is the net margin of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its Return on Equity (ROE) was 8.06%, with a year-on-year change of --.
What is the Return on Assets (ROA) of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its Return on Assets (ROA) was 7.80%, with a year-on-year change of --.
What is the operating profit of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its operating profit was -855.96K, with a year-on-year change of --.
What are the current assets of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its current assets were 1.95M, with a year-on-year change of --.
What are the total assets of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its total assets of BridgeBio Oncology Therapeutics Ord Shs were 194.42M, with a year-on-year change of --.
What are the total liabilities of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its total liabilities of BridgeBio Oncology Therapeutics Ord Shs were 5.71M, with a year-on-year change of --.
What is the total equity of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its total equity of BridgeBio Oncology Therapeutics Ord Shs was 188.72M, with a year-on-year change of --.
What is the net operating income of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its net operating income of BridgeBio Oncology Therapeutics Ord Shs was 7.60M, with a year-on-year change of --.
What is the net investment of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its net investment of BridgeBio Oncology Therapeutics Ord Shs was -184.00M, with a year-on-year change of --.
What is the net financing of BridgeBio Oncology Therapeutics Ord Shs?
According to BridgeBio Oncology Therapeutics Ord Shs's FY2024 earnings report, its net financing of BridgeBio Oncology Therapeutics Ord Shs was 186.46M, with a year-on-year change of --.
